Gummy Smile Due to Hypermobile Upper Lip
Conditions
Brief summary
The aim of the proposal study is to answer the question of how to manage gummy smiles due to hypermobile upper lip with less invasive and low risk level procedure . This trial will help the practitioners and the patients in taking the convenient decision to correct the gumminess to restore lip-gingival-dental harmony and enhance smile asthetics.
Detailed description
In this randomized clinical trial , two groups will be included to compare the effectiveness of a treatment modality of botulinum toxin-A injection , in the first group , on gingival display during smiling ,patient satisfaction , lower face esthetics ( upper lip length , upper lip vermillion length , interlabial gap , nasolabial angle) and the postoperative side effects . the comparator group will receive treatment by modified lip repositioning surgery ,to compare the results of the intervention group that can possibly obtained without undergoing surgery.
Interventions
adult patients with gummy smile due to hypermobile upper lip will receive Botulinum Toxin A Injection with a single injection1 cm lateral to the ala horizontally and 3 cm above the lip line vertically.
the surgical procedure will be done by removal of strip of epithelium by careful dissection and stabilizing the new mucosal margin to the gingiva to improve the gingival display in adult patients with gummy smile.
Sponsors
Study design
Masking description
single blind
Eligibility
Inclusion criteria
* Adults with age range from 18 - 30 years. * Excessive gingival display more than 3 mm during smiling. * Patients having hypermobile upper lip with or without (mild / moderate) vertical maxillary excess. * Patients with normal morphology of clinical crowns. * Normal lip separation (ILG) at rest * Medically free subjects.
Exclusion criteria
* Patients with systemic diseases or neuromuscular disorders. * Gummy smile with gingival display more than 8 mm during smiling. * Severly long face (VME) patients. * Patients with periodontal disease or gingival hyperplasia . * Medically compromised patients contraindicated for surgery . * Pregnant or lactating female patients. * Patients with inadequate attached gingiva .
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Patient satisfaction and postoperative side effects | at 4 weeks | it will be assessed using Questionnaire. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Improvement of gingival display upon smiling | at 4,8 and 12 weeks | it will be assessed using Digital ruler on DSS software |
| Lower face esthatics: a) upper lip length b) upper lip- vermillion length c) interlabial gap | at 4,8 and 12 weeks | it will be assessed using Digital ruler and angle measurement on DSS software |
| Lower face esthatics: d)nasolabial angle | at 4,8 and 12 weeks | it will be assessed using Digital angle measurement on DSS software |
| stability of gummy smile correction. | at the end of 24 weeks. | it will be assessed using Digital ruler on DSS software |